AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.12.23	AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis (RTTNews)
12.12.23	AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal (RTTNews)
11.12.23	AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH (RTTNews)
04.12.23	Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target (RTTNews)
01.12.23	AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme (RTTNews)
30.11.23	Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology (PR Newswire)
20.11.23	AstraZeneca Launches Evinova Healthtech Business (RTTNews)
17.11.23	AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer (RTTNews)
14.11.23	AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal (RTTNews)
09.11.23	AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial (RTTNews)
09.11.23	AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook (RTTNews)
01.11.23	AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder (RTTNews)
01.11.23	Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln (RTTNews)
24.10.23	AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent (RTTNews)
23.10.23	AZN : Enhertu Shows Survival Across Multiple HER2-Expressing Advanced Solid Tumors In Phase II Trial (RTTNews)
23.10.23	AstraZeneca : Phase III Trial Of Datopotamab Deruxtecan In Breast Cancer Shows Improvement In PFS (RTTNews)
23.10.23	AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment (RTTNews)
21.10.23	AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer (RTTNews)
21.10.23	AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses (RTTNews)
18.10.23	SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care (PR Newswire)
16.10.23	AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA (RTTNews)
16.10.23	Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL (RTTNews)
03.10.23	AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln (RTTNews)
22.09.23	AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan (RTTNews)
15.09.23	AstraZeneca's Enhertu Recommended For Approval In EU For Advanced Non-small Cell Lung Cancer (RTTNews)
12.09.23	AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal (RTTNews)
11.09.23	AstraZeneca's Tagrisso Plus Chemotherapy Extended Median PFS In EGFR-mutated Advanced Lung Cancer (RTTNews)
06.09.23	AstraZeneca: FDA Issues CRL Regarding SBLA Of Ultomiris In NMOSD (RTTNews)
04.09.23	AstraZeneca's Calquence Approved In China For Chronic Lymphocytic Leukaemia (RTTNews)
31.08.23	AZN : Enhertu Granted Breakthrough Therapy Designations In US For Multiple HER2 Expressing Cancers (RTTNews)
25.08.23	AstraZeneca Files Legal Challenge To Protect Access To Medicines For Cancer And Rare Diseases (RTTNews)
24.08.23	AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use (RTTNews)
28.07.23	AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up (RTTNews)
27.07.23	AstraZeneca: Phase II Trial Of Enhertu In Advanced Solid Tumors Shows Clinically Meaningful PFS & OS (RTTNews)
18.07.23	FDA Approves AstraZeneca And Sanofi's Beyfortus To Protect Infants Against RSV Disease (RTTNews)
03.07.23	AstraZeneca Says Dato-DXd Meets Dual Primary Endpoint Of PFS In Phase III Trial In Lung Cancer (RTTNews)
29.06.23	AstraZeneca: Long-term Survival Data Supports Use Of STRIDE Regimen To Treat Unresectable HCC (RTTNews)
19.06.23	AstraZeneca Plans To Spin Off China Business Amid Tensions: FT (RTTNews)
13.06.23	AstraZeneca Partners Vanguard Renewables To Use Renewable Natural Gas In The U.S. By End Of 2026 (RTTNews)
09.06.23	AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Lower Respiratory Tract Disease In Infants (RTTNews)
09.06.23	Syncona: Quell Signs Cell Therapy Deal With AstraZeneca Focused On Autoimmune Diseases (RTTNews)
05.06.23	AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial (RTTNews)
03.06.23	AstraZeneca Announces Positive Results From Interim Analysis Of DUO-O Phase III Trial (RTTNews)
01.06.23	AstraZeneca Announces Discontinuation Of IBD Development Programme For Brazikumab (RTTNews)
01.06.23	AstraZeneca's Lynparza Gets FDA Approval For BRCAm Prostate Cancer (RTTNews)
30.05.23	BioLight Inks Agreement With Alexion To Explore Technology For Diagnosis Of Retinal Diseases (RTTNews)
27.05.23	Biotech Stocks Facing FDA Decision In June 2023 (RTTNews)
26.05.23	AstraZeneca Reports Positive Results From DUO-E Phase III Trial - Quick Facts (RTTNews)
18.05.23	FibroGen Announces Positive Data From Phase 3 Study Of Roxadustat For Treatment Of Anemia (RTTNews)
17.05.23	AstraZeneca Reports Positive Trial Results Of Tagrisso Plus Chemotherapy In FLAURA2 Phase III Trial (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

29.04.25		AstraZeneca-Aktie verlustreich: AstraZeneca bleibt auch zum Jahresstart auf Wachstumskurs
14.04.25		NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude
04.04.25		Verluste in New York: NASDAQ 100 letztendlich tiefrot
04.04.25		Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse
04.04.25		Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch
04.04.25		Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone
03.04.25		Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100
03.04.25		Schwache Performance in New York: NASDAQ 100 implodiert am Nachmittag

29.04.25

AstraZeneca-Aktie verlustreich: AstraZeneca bleibt auch zum Jahresstart auf Wachstumskurs

14.04.25

NASDAQ 100-Papier AstraZeneca-Aktie: Mit dieser Dividende bereitet AstraZeneca Anlegern eine Freude

04.04.25

Verluste in New York: NASDAQ 100 letztendlich tiefrot

04.04.25

Schwache Performance in New York: NASDAQ 100-Anleger bekommen am Freitagnachmittag kalte Füsse

04.04.25

Schwacher Handel in New York: NASDAQ 100 am Mittag mit Kurseinbruch

04.04.25

Freitagshandel in New York: NASDAQ 100 beginnt die Sitzung weit in der Verlustzone

03.04.25

Börse New York: Letztendlich deutlicher Rückschlag für den NASDAQ 100

03.04.25

Schwache Performance in New York: NASDAQ 100 implodiert am Nachmittag

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	25.43	0.08 %	K V
Nestle	88.15	-0.01 %	K V
Zurich Insur Gr	593.20	-0.07 %	K V
Logitech Intl	63.36	-0.13 %	K V
Swiss Life Hldg	842.80	-0.38 %	K V
CieFinRichemont	143.15	-1.82 %	K V
Roche Hldg G	266.20	-1.92 %	K V
Part Grp Hldg	1’073.00	-2.14 %	K V
Lonza Grp	577.80	-2.50 %	K V
Kuehne+Nagel Int	182.75	-2.77 %	K V

AstraZeneca Aktie VALOR 163523 / ISIN US0463531089

Nachrichten zu AstraZeneca PLC (spons. ADRs)

Aktien Top/Flop

AstraZeneca Peer Group Nachrichten

Meistgelesene Nachrichten